• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:周武柳,胡馨一,吴斐华,金晶.水木涤浊饮治疗多囊卵巢综合征作用机制[J].药学研究,2026,45(9):967-974[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 234次   下载 215次 本文二维码信息
码上扫一扫!
水木涤浊饮治疗多囊卵巢综合征作用机制
周武柳1,胡馨一2,吴斐华1,金晶3
字体:加大+|默认|缩小-
(1.中国药科大学,江苏 南京 211198;2.南京医科大学,江苏 南京 211100;3.南京中医药大学附属医院,江苏 南京 210029)
摘要:
目的 研究水木涤浊饮(SMDZ)对脱氢表雄酮(dehydroepiandrosterone,DHEA)诱导小鼠多囊卵巢综合征(PCOS)的治疗作用及其潜在机制。方法>/b> 将50只SPF级雌性C57BL/6小鼠随机分为正常对照组、模型组、水木涤浊饮低、高剂量组和单纯给药组。连续21 d皮下注射DHEA建立PCOS模型,再灌胃水木涤浊饮21 d后检测小鼠动情周期、卵泡种类和激素水平,通过网络药理学筛选作用靶点,构建PCOS细胞模型验证靶点。结果 与模型组相比,水木涤浊饮高剂量组可纠正动情周期紊乱、卵泡发育异常、激素水平异常(均P<0.05)。经网络药理学分析和细胞实验验证,水木涤浊饮可增强P53通路中MDM2、CCND1、BCL2L1蛋白表达,从而抑制CASP8、CASP9、CDKN1A表达水平(均P<0.05),逆转颗粒细胞凋亡。结论 水木涤浊饮通过调控p53信号通路逆转颗粒细胞凋亡,改善PCOS。
关键词:  多囊卵巢综合征  水木涤浊饮  网络药理学
DOI:10.13506/j.cnki.jpr.2026.09.002
基金项目:中华中医药学会青年培养计划项目(No.202403-002);江苏省高层次人才培养计划(“333”工程);江苏省中医院高峰学术人才培养项目(No.k2026yrc57)
收稿日期:2026-02-26   修回日期:2026-04-02   出版日期:2026-09-30
The mechanism of action of Shuimudizhuo Decoction in the treatment of polycystic ovary syndrome
ZHOU Wuliu1,HU Xinyi2,WU Feihua1,JIN Jing3
(1.China Pharmaceutical University,Nanjing 211198,China;2.Nanjing Medical University,Nanjing 211100,China;3.Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210000,China)
Abstract:
Objective>/b> To investigate the therapeutic effect of Shuimudizhuo Decoction on dehydroepiandrosterone (DHEA)-induced polycystic ovary syndrome(PCOS) mice and its potential mechanism. Methods Fifty SPF-grade female C57BL/6 mice were randomly divided into a blank control group, a model group, low-dose and high-dose groups of Shuimudizhuo Decoction, and drug-only group. The PCOS model was established by subcutaneous injection of DHEA for 21 days. After 21 days of gavage of Shuimudizhuo Decoction, the estrous cycle, types of follicles, ovarian histology and hormone levels of mice were analyzed. Target screening was performed through network pharmacology and verified in vitro. Results Compared with the model group, the high-dose group of Shuimudizhuo Decoction could correct estrous cycle disorders, abnormal follicular development, and abnormal hormone levels (all P<0.05). Through network pharmacological analysis and in vitro experiments, it has been verified that Shuimudizhuo Decoction may reverse granulosa cell apoptosis by enhancing the expression of MDM2、CCND1、BCL2L1 proteins, inhibiting the expression of CASP8, CASP9, and CDKN1A proteins, and enhancing the expression of CCND1 protein (all P<0.05). Conclusion Shuimudizhuo Decoction reverses granulosa cell apoptosis and improves PCOS by regulating the p53 signaling pathway.
Key words:  Polycystic Ovary syndrome  Shuimudizhuo Decoction  Network pharmacology
今日访问量:2271    总访问量:55338612
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司